Related Experiment Video
Updated: Aug 8, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells
S Vannucchi1, Z A Percario, M V Chiantore
1Laboratory of Virology, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Abstract:
Type I Interferon (IFN) and all-trans retinoic acid (RA) inhibit cell proliferation of squamous carcinoma cell lines (SCC). Examinations of growth-affected cell populations show that SCC lines ME-180 and SiHa treated with IFN-beta undergo a specific slower progression through the S phase that seems to trigger cellular death. In combination treatment RA potentiates IFN-beta effect in SCC ME-180 but not in SiHa cell line, partially resistant to RA antiproliferative action. RA added as single agent affects cell proliferation differently by inducing a slight G1 accumulation. The IFN-beta-induced S phase lengthening parallels the increased expression of PML, a nuclear phosphoprotein specifically up-regulated at transcriptional level by IFN, whose overexpression induces cell growth inhibition and tumor suppression. We report that PML up-regulation may account for the alteration of cell cycle progression induced by IFN-beta in SCC by infecting cells with PML-PINCO recombinant retrovirus carrying the PML-3 cDNA under the control of the 5' LTR. In fact PML overexpression reproduces the IFN-beta-induced S phase lengthening. These findings provide important insight into the mechanism of tumor suppressing function of PML and could allow PML to be included in the pathways responsible for IFN-induced cell growth suppression.
Insights
Type I Interferon (IFN) and all-trans retinoic acid (RA) inhibit squamous cell carcinoma (SCC) proliferation. PML protein up-regulation by IFN-beta causes cell cycle arrest, offering insights into tumor suppression mechanisms.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Type I Interferon (IFN) and all-trans retinoic acid (RA) are known to inhibit cancer cell proliferation.
- Squamous cell carcinoma (SCC) lines, such as ME-180 and SiHa, exhibit sensitivity to these agents, but the underlying mechanisms require further elucidation.
Purpose of the Study:
- To investigate the cell cycle effects of IFN-beta and RA on SCC.
- To explore the role of PML (Promyelocytic Leukemia) protein in IFN-beta-induced growth inhibition.
- To determine if PML overexpression can replicate the cell cycle alterations observed with IFN-beta treatment.
Main Methods:
- Treatment of SCC cell lines (ME-180, SiHa) with IFN-beta and/or RA.
- Flow cytometry analysis to assess cell cycle progression (S phase, G1 accumulation).
- Retroviral transduction using PML-PINCO to overexpress PML protein in SCC cells.
Main Results:
- IFN-beta treatment induced a specific S phase delay and subsequent cell death in SCC lines.
- RA potentiated IFN-beta's effect in ME-180 cells but had limited impact on the RA-resistant SiHa line.
- IFN-beta treatment led to increased PML expression, which correlated with S phase lengthening.
- Overexpression of PML via retroviral vectors reproduced the IFN-beta-induced S phase delay.
Conclusions:
- PML protein up-regulation is a key mechanism by which IFN-beta inhibits SCC cell cycle progression.
- PML overexpression alone can induce S phase lengthening, suggesting its direct role in IFN-beta's anti-proliferative effects.
- These findings highlight the tumor-suppressive function of PML and its potential involvement in IFN-mediated cancer therapies.
More Related Videos
10:48Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Published on: May 15, 2014
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects (TEdeff) in Cancers
Published on: September 26, 2019
Related Concept Videos
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Inhibition of Cdk Activity
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
Inhibitors of Viral Protein Synthesis